Skip to main content
Clinical Trials/KCT0005353
KCT0005353
Recruiting
未知

sefulness of heart rate variability (HRV) as non-invasive objective parameters for predicting the occurrence of chemotherapy-induced peripheral neuropathy (CIPN) in gastrointestinal cancer patients precribed chemotherapy

niversity of Ulsan0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Ulsan
Enrollment
100
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
niversity of Ulsan

Eligibility Criteria

Inclusion Criteria

  • 1\) Adults over 18 years old
  • 2\) Histologically confirmed cancer patients
  • 3\) Eastern Cooperative Oncology Group (ECOG) evaluation performance is \= 1
  • 4\) Patients who are prescribed chemotherapy including platinum, paclitaxel, docetaxel, and vinca alkaloid
  • 5\) Patients who understand the purpose of the study and can consent in writing without impairment of cognitive function

Exclusion Criteria

  • 1\) Patients with previous history of chemotherapy
  • 2\) Patients with diseases that affect other autonomic neuropathy, such as diabetic neuropathy, Parkinson's disease, vitamin B12 deficiency
  • 3\) Patients with a history of hospitalization for acute medical history within the last 1 month

Outcomes

Primary Outcomes

Not specified

Similar Trials